A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone

NCT04255238 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

468

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Gemigliptin 50mg
DRUG: Dapagliflozin 10mg

Sponsor

LG Chem